This compound is a phosphonate intermediate specifically designed for the synthesis of antiviral prodrugs. Its structure features a purine base and a phosphonate ester group, which are key to its role in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 379270-35-6
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, diphenyl ester
pharmaceutical intermediate
Tenofovir disoproxil
pharmaceutical raw material
Tenofovir monohydrate
pharmaceutical raw material
5-Methyl-3,4-diphenylisoxazole
pharmaceutical intermediate
4-phenoxyphthalic acid
pharmaceutical intermediate
3-Trifluoromethylpyridine
pharmaceutical intermediate
4-oxotretinoin
pharmaceutical intermediate
Tenofovir alafenamide
pharmaceutical raw material
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphinic acid
ITAMCOCNZJPJDF-LLVKDONJSA-N
C[C@H](CN1C=NC2=C(N=CN=C21)N)OCP(=O)(O)OC3=CC=CC=C3